Group Action Lawyers
Latest News & Updates

Category: Products

medical device recall
November 09, 2018
Bone cement complications from product recall

A regulator warning earlier this year stemmed from bone cement complications caused by an issue with the product itself.

A risk of the need for revision surgery from the use of Optipac 40 Refobacin Revision and Optipac 80 Refobacin Revision was identified. Manufacturer, Biomet UK Limited, issued a Field Safety Notice at the end of last year. The UK’s medical regulator, the MHRA (Medicines and Healthcare products Regulatory Agency), issued their own recall advice off the back of the findings.

Anyone who has suffered with bone cement complications may find the reason is to do with the product itself as opposed to failed surgery.

Continue Reading…

grass
October 19, 2018
The Roundup weed killer cancer lawsuit

The Roundup weed killer cancer lawsuit alleges that the product can be carcinogenic. The ingredient at the heart of the case is glyphosate.

Although makers of Roundup, Monsanto, are fiercely defending the hundreds of claims brought against them, a claim has settled to the tune of over £200m. Monsanto say there is no viable evidence that glyphosate causes cancer. The common herbicide is found in many household and farming products.

The Roundup weed killer cancer lawsuits allege that glyphosate is carcinogenic. Opinions remain divided.

Continue Reading…

medical device recall
October 12, 2018
Hernia mesh compensation advice

We can help you with hernia mesh compensation advice. We can also offer No Win, No Fee representation for people suffering complications.

Some 170,000 who have received hernia mesh implants may well be suffering complications. In the same way we’ve been helping people for the vaginal mesh complications, we’re also able to represent hernia mesh claimants too.

The severity of the problems that victims can be left with can be serious and permanent. It’s important that anyone who has suffered complications comes forward for advice.

Continue Reading…

breast implant concerns
October 05, 2018
Breast implants cancer reporting intensifies

There has been an intensification in the need for breast implants cancer reporting. This stems from a greater focus on identifying links between implants and certain types of cancer.

We know all too well about the problems that breast implants can caused. We’re still battling for justice for women affected by the PIP Breast Implant scandal. We’ve already recovered over £1.3m in damages, and we continue to fight for UK victims here and in France.

Regulators continue to investigate links between breast implants and rare forms of cancer. Both clinicians and patients are being asked to be aware of the need to take precautions and report adverse incidents.

Continue Reading…

medical device recall
September 14, 2018
Advice for starting your vaginal mesh lawsuit

A large number of vaginal mesh lawsuits are already being pursued, and if you need advice for starting yours, you can contact the team for advice today.

Thousands of women have reported suffering from mesh implant complications, and the UK has been slow to take real action to safeguard women and ensure compensation is awarded for victims who are now suffering.

Some of the problems people can suffer from can be irreversible, so it’s important for anyone suffering with complications to start their vaginal mesh lawsuit as soon as they can; especially given that time limitations for new cases can be tricky.

Continue Reading…

eye claims
September 07, 2018
Latanoprost Timolol eye drops recall

A Latanoprost Timolol eye drops recall has been announced by the Medicines and Healthcare Regulatory Authority (MHRA).

The company behind the eye drops, FDC Pharma, are recalling a batch due to what has been classed as an ‘out of specification result for an unknown impurity’ that was identified during testing. Medical professionals are to stop providing the eye drops to patients, and suppliers and distributors are to cease moving the eye drops as well.

The NHS has been pushing the news throughout the Service to ensure batches affected by the Latanoprost Timolol eye drops recall are not used.

Continue Reading…

August 26, 2018
The latest talcum powder asbestos trial

One of the latest talcum powder asbestos trial cases is underway as a 94-year-old lady is claiming that her fatal mesothelioma was caused by talc.

This is one of the many cases being pursued in an action where millions of pounds have been awarded to victims who have successfully claimed that their deadly asbestos-related illnesses have been caused by talcum powder containing the deadly substance.

The talcum powder asbestos action is one of the biggest medical product issues of our time, and it could be set to go on for a number of years.

Continue Reading…

court orders payout
August 15, 2018
Pelvic mesh suits continue against Boston Scientific

Pelvic mesh suits are to continue against pharmaceutical giant Boston Scientific after a Judge denied an attempt to dismiss some 800 claims.

The major pharmaceutical companies like Boston Scientific and Johnson and Johnson seem to be trying their hardest to dismiss the thousands of claims that are currently being made against them in them around the world. The UK is somewhat behind in terms of taking full legal action for victims pursuing pelvic mesh suits, and it’s a legal action we’re involved in.

This latest failed effort to dismiss claims is another small victory in what continues to be a long, hard fight for justice.

Continue Reading…

pelvic mesh inquiry vaginal mesh implants concerns
August 08, 2018
Pelvic mesh implant complications lead to NHS halt

The increasing number of pelvic mesh implant complications has finally forced the NHS to put a widespread halt on the use of the procedure as more and more women come forward with problems over the use of transvaginal mesh and transvaginal tape.

We’ve been advising women suffering mesh implant complications since the start of 2013, and our Group Action Lawyers are involved in legal action over the use of the devices. We wholeheartedly welcome the NHS pause on the use of the implants that’s arisen from a review chaired by Baroness Julia Cumberlege.

This may prove to be another crucial step forward toward justice for the many women who have suffered catastrophic and lifelong injuries caused by mesh implant complications.

Continue Reading…

tesla autopilot investigation
August 01, 2018
Stagecoach self-drive buses to be tested

Stagecoach self-drive buses are to be tested in depots, marking a potential shift toward self-driving technology on UK roads.

Currently, self-drive vehicles are not yet fully legal for road-use, but the government plans to have them on pubic roads as soon as possible. We have the likes of Tesla testing their self-drive technology right now, despite there being a number of accidents (and fatalities) so far that are linked to self-drive technology.

We remain incredibly concerned about these hastening developments.

Continue Reading…

unsatisfactory safety information
July 25, 2018
Slime borax ingredient ‘toxic’ to children

The levels of a slime borax ingredient contained in the popular children’s toy has been found to be at potentially ‘toxic’ levels in eight of the leading slime products.

According to research conducted by consumer action group Which?, eight of the 11 leading slime products tested contained amounts of boron – a chemical in borax – deemed to be unsafe, leaving children at risk of irritation, diarrhoea, vomiting and cramps.

According to the research, the levels of the dangerous chemical may not be clearly listed on the ingredients and may be described as ‘contact lens solution’ which contains borax.

Continue Reading…

unsatisfactory safety information
July 19, 2018
Phenytoin 90mg/5ml Oral Suspension immediate discontinuation

There has been an immediate discontinuation of unlicensed medicine Phenytoin 90mg/5ml Oral Suspension and a recall of the product.

The medication, manufactured by Rosemont Pharmaceuticals Limited, is now no longer on the shelves having been recalled and discontinued with immediate affect as a result of worrying data that suggested that the medication becomes difficult to resuspend over shelf-life.

Patients who use the Phenytoin 90mg/5ml Oral Suspension are being told to contact their doctors for more information and advice about the issues that have been identified.

Continue Reading…